EDGAR Filing Documents for 0001640455-17-000033

Form 8-K - Current report:

SEC Accession No. 0001640455-17-000033

Filing Date

2017-05-23

Accepted

2017-05-23 11:57:48

Documents

Period of Report

2017-05-19

Items

Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	jnce05xx20178k.htm	8-K	33348
2	EXHIBIT 10.1	jnce05xx2017exhibt101.htm	EX-10.1	42042
3	EXHIBIT 10.2	jnce05xx2017exhibit102.htm	EX-10.2	25235
4		leaseterminationexhibita.jpg	GRAPHIC	24494
	Complete submission text file	0001640455-17-000033.txt		135574

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139

Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840

Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 17863103
SIC: 2836 Biological Products, (No Diagnostic Substances)